Press Releases

Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018

September 24, 2014

Wellesley, Mass., September 19, 2014 –BCC Research (www.bccresearch.com) reveals in its new report, ANTIFUNGAL DRUGS: TECHNOLOGIES AND GLOBAL MARKETS, the global market for human antifungal therapeutics is expected to grow to nearly $13.9 billion by 2018, with a five-year compound annual growth rate (CAGR) of 3.2%.  The over-the-counter (OTC) segment is growing at a steady 3.8% CAGR.

 Given the current world economic situation, which is often presenting lower sales, coupled with the incidence of increasing mortality and the severity of fungal infection, there is a need for effective products that are cost-effective and innovative.

 In non-U.S. and –European countries, the total sales of all human antifungal products reached $11.8 billion in 2013 and are anticipated to reach $13.8 billion in 2018. It is expected that the OTC/alternative portion of the global antifungal market will continue to grow. OTC sales reached $5.4 billion in 2013 and are forecast to grow to $6.5 billion in 2018.

 “Increased use of antibiotics and immunosuppressive drugs such as corticosteroids are major factors contributing to higher frequency of fungal infections,” says BCC Research pharmaceutical analyst Mary Anne Crandall. “By disrupting normal bacterial colonization and suppressing the immune system, antibiotics and immunosuppressive drugs create an environment within the body in which fungi can thrive.”

 ANTIFUNGAL DRUGS: TECHNOLOGIES AND GLOBAL MARKETS provides an overview of the global human antifungal market and assesses its growth potential over the five-year period from 2013 to 2018. It also covers approved human therapeutics, with a heavy focus on therapeutics in early development.

   

SAMPLE FIGURE
GLOBAL MARKET FORECAST FOR HUMAN ANTIFUNGAL THERAPEUTICS, BY GEOGRAPHIC REGION, 2012-2018
($ MILLIONS)
GLOBAL MARKET FORECAST FOR HUMAN ANTIFUNGAL THERAPEUTICS, BY GEOGRAPHIC REGION, 2012-2018
To Contact us, click here  help


Source: BCC Research

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.

Antifungal Drugs: Technologies and Global Markets( PHM029E )
Publish Date: Jun 2014    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.